Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
OptimizeRx Corp. (OPRX) had Cash Flow from Financial Activities of $-8.80M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$32.24M |
|
$5.02M |
|
$8.14M |
|
$24.10M |
|
$23.67M |
|
$8.57M |
|
$-1.10M |
|
$7.47M |
|
$7.47M |
|
$5.02M |
|
$5.02M |
|
$5.02M |
|
$5.02M |
|
$8.57M |
|
-- |
|
18.66M |
|
19.38M |
|
$0.27 |
|
$0.26 |
|
| Balance Sheet Financials | |
$64.72M |
|
$0.11M |
|
$112.20M |
|
$176.92M |
|
$21.26M |
|
$21.42M |
|
$27.36M |
|
$48.62M |
|
$128.29M |
|
$16.63M |
|
$128.29M |
|
18.76M |
|
| Cash Flow Statement Financials | |
$18.71M |
|
$0.07M |
|
|
Cash Flow from Financial Activities |
$-8.80M |
$13.38M |
|
$23.36M |
|
$9.98M |
|
$6.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|